rs1468231556
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000082.4(ERCC8):c.600dupT(p.Ile201TyrfsTer8) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000197 in 152,090 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000082.4 frameshift
Scores
Clinical Significance
Conservation
Publications
- Cockayne syndrome type 1Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Genomics England PanelApp, PanelApp Australia, ClinGen, Myriad Women’s Health, Labcorp Genetics (formerly Invitae), G2P
- UV-sensitive syndrome 2Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
- Cockayne syndrome type 2Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- UV-sensitive syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ERCC8 | NM_000082.4 | c.600dupT | p.Ile201TyrfsTer8 | frameshift_variant | Exon 7 of 12 | ENST00000676185.1 | NP_000073.1 | |
| ERCC8 | NM_001007233.3 | c.426dupT | p.Ile143TyrfsTer8 | frameshift_variant | Exon 8 of 13 | NP_001007234.1 | ||
| ERCC8 | NM_001290285.2 | c.141dupT | p.Ile48TyrfsTer8 | frameshift_variant | Exon 6 of 11 | NP_001277214.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152090Hom.: 0 Cov.: 32 show subpopulations
GnomAD4 exome Cov.: 29
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152090Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74294 show subpopulations
ClinVar
Submissions by phenotype
not provided Pathogenic:2
This sequence change creates a premature translational stop signal (p.Ile201Tyrfs*8) in the ERCC8 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ERCC8 are known to be pathogenic (PMID: 29572252). This variant is present in population databases (no rsID available, gnomAD no frequency). For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 553300). This premature translational stop signal has been observed in individual(s) with Cockayne syndrome (PMID: 22829088). -
Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at a significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 34105807, 22829088, 31589614) -
Cockayne syndrome type 1 Pathogenic:2
This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com. -
The c.600dup;p.(Ile201Tyrfs*8) is a null frameshift variant (NMD) in the ERCC8 gene and predicts alteration of the nonsense-mediate decay - NMD is present in a relevantexon to the transcript -PVS1. This sequence change has been observed in affected individual(s) and ClinVar contains an entry for this variant (ClinVar ID: 553300) - PS4. The variant is present at low allele frequencies population databases (rs1468231556– gnomAD 0.001973%; ABraOM no frequency - http://abraom.ib.usp.br/) - PM2_supporting. The p.(Ile201Tyrfs*8) was detected homozygous state in analyzed sample -PM3. In summary, the currently available evidence indicates that the variant is pathogenic. -
Cockayne syndrome type 1;C3553298:UV-sensitive syndrome 2 Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at